


Searching News Database: CARE 2
HSMN NewsFeed - 3 Sep 2024
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
HSMN NewsFeed - 29 Sep 2022
MolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
MolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
HSMN NewsFeed - 10 Sep 2020
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
HSMN NewsFeed - 24 Jan 2019
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
HSMN NewsFeed - 31 May 2018
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
HSMN NewsFeed - 30 Jan 2015
Vomaris and Arthrex announce exclusive global distribution agreement for Procellera(R) Technology
Vomaris and Arthrex announce exclusive global distribution agreement for Procellera(R) Technology
HSMN NewsFeed - 29 Feb 2012
Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints
Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints
HSMN NewsFeed - 27 Oct 2011
ULURU Inc. Announces Additional Data Supporting Altrazeal(R) Use in Diabetic Foot Ulcers
ULURU Inc. Announces Additional Data Supporting Altrazeal(R) Use in Diabetic Foot Ulcers
HSMN NewsFeed - 18 Nov 2010
University Hospital of Nantes Presents 18-Year Experience with SynCardia’s Total Artificial Heart
University Hospital of Nantes Presents 18-Year Experience with SynCardia’s Total Artificial Heart
HSMN NewsFeed - 25 Jun 2010
Medtronic Begins Enrollment in ASPIRE Pivotal Study of Low Glucose Suspend Integrated System
Medtronic Begins Enrollment in ASPIRE Pivotal Study of Low Glucose Suspend Integrated System
HSMN NewsFeed - 19 Mar 2010
Medtronic Receives FDA Panel's Unanimous Recommendation for Approval of Revo MRI SureScan Pacing System
Medtronic Receives FDA Panel's Unanimous Recommendation for Approval of Revo MRI SureScan Pacing System
HSMN NewsFeed - 2 May 2008
ConvaTec Upgrades Flexi-Seal(R) Fecal Management System to Increase Ease of Use
ConvaTec Upgrades Flexi-Seal(R) Fecal Management System to Increase Ease of Use
HSMN NewsFeed - 21 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
HSMN NewsFeed - 19 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
HSMN NewsFeed - 11 Dec 2007
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
HSMN NewsFeed - 7 Nov 2007
Fresenius Medical Care Announces: Continued Positive Data from CARE-2 Database
Fresenius Medical Care Announces: Continued Positive Data from CARE-2 Database
HSMN NewsFeed - 20 Aug 2007
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
HSMN NewsFeed - 11 Jan 2007
The European Commission Approves First and Only Enzyme Replacement Therapy for Hunter Syndrome
The European Commission Approves First and Only Enzyme Replacement Therapy for Hunter Syndrome
HSMN NewsFeed - 26 Jun 2006
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Additional items found! 25
Members Archive contains
25 additional stories matching:
CARE 2
(Password required)
CARE 2
(Password required)
